The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 9, Issue 2, 2000, Pages 225-227

  Madeleine, Margaret M ^a   Shera, Katherine ^a   Schwartz, Stephen M ^a,b   Daling, Janet R ^a,b   Galloway, Denise A ^a,c   Wipf, Gregory C ^a   Carter, Joseph J ^a   McKnight, Barbara ^b   McDougall, James K ^a,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ONCOPROTEIN; PROLINE; PROTEIN P53; VIRUS DNA; VIRUS PROTEIN;

ADULT; ARTICLE; CANCER RISK; CODON; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; UNITED STATES; UTERINE CERVIX CANCER; WART VIRUS;

ADULT; ARGININE; CARCINOMA, SQUAMOUS CELL; CODON; FEMALE; GENES, P53; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; PROLINE; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0033996707     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I. M., Matlashewski, G., and Banks, L. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature (Lond.), 393: 229-234, 1998.
2. Werness, B. A., Levine, A. J., and Howley, P. M. Association of human papillomavirus types 16 and 18E6 proteins with p53. Science (Washington DC), 248: 76-79, 1990.
3. Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., and Howley, P. M. The E5 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell, 63: 1129-1136, 1990.
4. Daling, J. R., Madeleine, M. M., McKnight, B., Carter, J. J., Wipf, G. C., Ashley, R., Schwartz, S. M., Beckmann, A. M., Hagensee, M. E., Mandelson, M. T., and Galloway, D. A. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol. Biomark. Prev., 5: 541-548, 1996.
5. Carter, J. J., Koutsky, L. A., Wipf, G. C., Christensen, N. D., Lee, S. K., Kuypers, J., Kiviat, N., and Galloway, D. A. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J. Infect. Dis., 174: 927-936, 1996.
6. Harlow, E., Williamson, N. M., Ralston, R., Helfman, D. M., and Adams, T. E. Molecular cloning and in vitro expression of a cDNA clone for human cellular tumor antigen p53. Mol. Cell. Biol., 5: 1601-1610, 1985.
7. EGRET version 1.02.07. Cambridge, MA: Cytel Software Corp., 1991.
8. Dean, A., Dean, J., Coulumbier, D., Brendel, K., Smith, D., Burton, A., Dicker, R., Sullivan, K., Fagan, R., and Arner, T. Epi Info, Version 6. Atlanta, GA: Centers for Disease Control, 1994.
9. Rosenthal, A. N., Ryan, A., Al-Jehani, R. M., Storey, A., Harwood, C. A., and Jacobs, I. J. p53 codon 72 polymorphism and risk of cervical cancer in UK. Lancet, 352: 871-872, 1998.
10. Giannoudis, A., Graham, D., Southern, S., and Herrington, C. p53 codon 72 ARG/PRO polymorphism is not related to HPV type or lesion grade in low-and high-grade squamous intra-epithelial lesions and invasive squamous carcinoma of the cervix. Int. J. Cancer, 83: 66-69, 1999.
11. Lanham, S., Campvell, I., Watt, P., and Gornall, R. p53 polymorphism and risk of cervical cancer. Lancet, 352: 1631, 1998.
12. Helland, A., Legerod, A., Johnsen, H., Olsen, A. O., Skovlund, E., and Borresen-Dale, A-L. "p53 polymorphism and the risk of cervical cancer" (Letter). Nature (Lond.), 396: 530-531, 1998.
13. Josefsson, A. M., Magnusson, P. K. E., Ylitalo, N., Quafort-Tubbin, P., Ponten, J., Adami, H. O., and Gyllesten, U. B. "p53 polymorphism and the risk of cervical cancer" (Letter). Nature (Lond.), 396: 531, 1998.
14. Hildesheim, A., Schiffman, M., Brinton, L. A., Fraumeni, J. F., Jr., Herrero, R., Bratti, M. C., Schwartz, P., Mortel, R., Barnes, W., Greenberg, M., McGowan, L., Scott, D. R., Martin, M., Herrera, J. E., Carrington, M. "p53 polymorphism and the risk of cervical cancer" (Letter). Nature (Lond.), 396: 531-532, 1998.
15. Hayes, V., Hofstra, R., Buys, H., Hollema, H., and van der Zee, A. Homozygous arginine-72 in wild type p53 and risk of cervical cancer. Lancet, 352: 1756, 1998.
16. Szarka, K., Veress, G., Konya, J., and Gergely, L. Frequency of p53 codon 72 genotypes in human papillomavirus associated squamous intraepithelial lesions and cervical cancer. Anticancer Res. 19: 2377-2379, 1999.
17. Bertorelle, R., Chieco-Bianchi, L., and Del Mistro, A. Papillomavirus and p53 codon 72 polymorphism. Int. J. Cancer, 82: 616-617, 1999.
18. Klaes, R., Ridder, R., Schaefer, U., Benner, A., and von KnebelDoeberitz, M. No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer. J. Mol. Med., 77: 299-302, 1999.
19. Minaguchi, T., Kanamori, Y., Matushima, M., Yoshikawa, H., Taketani, Y., and Nakamura, Y. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Res., 58: 4585-4586, 1998.
20. Zehbe, I., Voglino, G., Wilander, E., Genta, F., and Tommasino, M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet, 354: 218-219, 1999.
21. Carter, J., and Galloway, D. Humoral immune response to human papillomavirus infection. Clin. Dermatol., 15: 249-259, 1997.